AKBA
Akebia Therapeutics, Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney disease. The firm also involves in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.
Market Cap: 929 Million
Primary Exchange: NASDAQ
Website: http://www.akebia.com
Shares Outstanding: 119 Million
Float: 106 Million
Dividend: (%)
Beta: 1.84077549684751
Sector: Health Technology
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1938 trading days
From: 2014-06-20 To: 2020-01-27
Lowest Point:
Akebia Therapeutics Launches AkebiaCares, an Enhanced Patient Access Program for People with Chronic Kidney Disease
via: Business Wire at 2019-06-11 03:30:00:000
AkebiaCares connects patients, caregivers and health care providers with resources and important information to support greater access to therapy Akebia Therapeutics, Inc. (Nasdaq: AKBA) a biopharmaceutical company focused on the development and commercialization of therapeutics for… read more...
Akebia Therapeutics Launches AkebiaCares, an Enhanced Patient Access Program for People with Chronic Kidney Disease
via: Business Wire at 2019-06-11 03:30:00:000
AkebiaCares connects patients, caregivers and health care providers with resources and important information to support greater access to therapy Akebia Therapeutics, Inc. (Nasdaq: AKBA) a biopharmaceutical company focused on the development and commercialization of therapeutics for… read more...
Akebia Therapeutics Launches AkebiaCares, an Enhanced Patient Access Program for People with Chronic Kidney Disease
via: Business Wire at 2019-06-11 03:30:00:000
AkebiaCares connects patients, caregivers and health care providers with resources and important information to support greater access to therapy Akebia Therapeutics, Inc. (Nasdaq: AKBA) a biopharmaceutical company focused on the development and commercialization of therapeutics for… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|